Last reviewed · How we verify
intravenous infusion NaCl
Intravenous infusion of NaCl helps to restore and maintain fluid balance in the body.
Intravenous infusion of NaCl helps to restore and maintain fluid balance in the body. Used for Treatment of dehydration and hypovolemia.
At a glance
| Generic name | intravenous infusion NaCl |
|---|---|
| Also known as | 0,9% NaCl |
| Sponsor | Medical University of Bialystok |
| Modality | Small molecule |
| Therapeutic area | Fluid Resuscitation |
| Phase | Phase 3 |
Mechanism of action
This is achieved by replenishing sodium and chloride ions, which are essential for various bodily functions, including nerve and muscle function, and maintaining proper blood pressure.
Approved indications
- Treatment of dehydration and hypovolemia
Common side effects
- Hypersensitivity reactions
- Fluid overload
Key clinical trials
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies (PHASE1)
- MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) (PHASE3)
- Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer (PHASE1)
- Metabolic Effects of the Exercise-metabolite Lac-Phe (NA)
- Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation (NA)
- Intravenous Lidocaine Infusion in Lumbar Fusion Surgery (NA)
- The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- intravenous infusion NaCl CI brief — competitive landscape report
- intravenous infusion NaCl updates RSS · CI watch RSS
- Medical University of Bialystok portfolio CI